Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Akram Hernández-Vásquez 4 Articles
Non-vaccination Against COVID-19 Among Venezuelan Refugees and Migrants Adults in Peru: A Cross-sectional Study, 2022
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
J Prev Med Public Health. 2023;56(5):397-406.   Published online August 17, 2023
DOI: https://doi.org/10.3961/jpmph.23.078
  • 2,328 View
  • 166 Download
AbstractAbstract AbstractSummary PDF
Objectives
The purpose of this study was to determine factors associated with non-vaccination against coronavirus disease 2019 (COVID-19) among the Venezuelan immigrant population residing in Peru.
Methods
A cross-sectional study was conducted using data obtained from the Second Survey of the Venezuelan Population Residing in Peru in 2022. The dependent variable was vaccination status against COVID-19. The independent variables included socio-demographic, economic, and migratory characteristics of the included population. Crude and adjusted generalized linear Poisson-family models were used to calculate prevalence ratios with 95% confidence intervals (CIs).
Results
A total of 7739 Venezuelan migrants aged 18 years or older were included. The proportion of non-vaccination against COVID-19 was 5.7%. Regarding associated factors, unemployment (adjusted prevalence ratio [aPR], 1.31; 95% CI, 1.04 to 1.65) was linked to an increased likelihood of not being vaccinated against COVID-19. In contrast, women (aPR, 0.76; 95% CI, 0.61 to 0.95), possessing a migration permit (aPR, 0.41; 95% CI, 0.31 to 0.54), and having health insurance (aPR, 0.47; 95% CI, 0.27 to 0.81) were associated with a decreased likelihood of being unvaccinated.
Conclusions
The primary governmental and non-governmental institutions responsible for supporting and protecting the Venezuelan migrant and refugee population should improve vaccination access by issuing migration permits and providing health insurance.
Summary
Key Message
• Vaccination against COVID-19 is a strategy that should be provided equitably to the entire population. However, there are vulnerable groups such as Venezuelan migrants who have structural, cultural and socioeconomic barriers that limit access to this prevention system. • In Peru, about 6% of Venezuelan migrants have not received the complete vaccination schedule against COVID-19 due to the lack of employment in this population. In fact, the majority (61.9%) of Venezuelan migrants have only received two doses of the COVID-19 vaccine by February 2022.
Socio-demographic Determinants of Low Physical Activity in Peruvian Adults: Results of a Population-based Survey Performed in 2017-2018
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
J Prev Med Public Health. 2021;54(6):461-470.   Published online November 7, 2021
DOI: https://doi.org/10.3961/jpmph.21.418
  • 3,342 View
  • 98 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Objectives
The objective of this study was to determine the prevalence of low physical activity (PA) in Peruvian adults and to identify associated factors.
Methods
An analytical study was performed using data from the 2017-2018 Nutritional Food Surveillance by Life Stages survey. The outcome variable was low PA (yes or no), assessed using the International Physical Activity Questionnaire-short form. Prevalence ratios were estimated as a measure of association.
Results
Among the 1045 persons included in the analysis, the age-standardized prevalence of low PA was 61.9%. The adjusted model showed that being female and migrating from a rural to an urban area in the last 5 years were associated with a higher probability of having low PA than males and individuals who had not migrated, while residing in rural highlands and jungle areas was associated with a reduced probability of having low PA compared to people residing in other geographic domains.
Conclusions
Being a female and migration from a rural to an urban area in the last 5 years were associated with a higher likelihood of having low PA. Therefore, promotion and prevention strategies related to PA are required, especially in the female and migrant populations.
Summary

Citations

Citations to this article as recorded by  
  • Individualized Biological Age as a Predictor of Disease: Korean Genome and Epidemiology Study (KoGES) Cohort
    Seokyung An, Choonghyun Ahn, Sungji Moon, Eun Ji Sim, Sue-Kyung Park
    Journal of Personalized Medicine.2022; 12(3): 505.     CrossRef
  • Association between Altitude and the Framingham Risk Score: A Cross-Sectional Study in the Peruvian Adult Population
    Akram Hernández-Vásquez, Rodrigo Vargas-Fernández, Manuel Chacón-Diaz
    International Journal of Environmental Research and Public Health.2022; 19(7): 3838.     CrossRef
  • Prevalence of Prehypertension and Associated Cardiovascular Risk Profiles among Adults in Peru: Findings from a Nationwide Population-Based Study
    Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
    International Journal of Environmental Research and Public Health.2022; 19(13): 7867.     CrossRef
Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study
Akram Hernández-Vásquez, Diego Azañedo, Rodrigo Vargas-Fernández, Guido Bendezu-Quispe
J Prev Med Public Health. 2020;53(4):211-219.   Published online May 28, 2020
DOI: https://doi.org/10.3961/jpmph.20.186
  • 8,607 View
  • 2,339 Download
  • 24 Crossref
AbstractAbstract PDF
Objectives
The goal of this study was to identify chronic conditions and multimorbidity patterns in patients with coronavirus disease 2019 (COVID-19) and to examine their associations with pneumonia and death.
Methods
This cross-sectional study analyzed the official data of COVID-19 patients in Mexico through May 18, 2020 (released by the Secretaría de Salud de México). Adjusted logistic regression models were applied to assess the associations of comorbidities with pneumonia and death. The marginal effects were estimated, and the probability of pneumonia or death according to the number of comorbidities was graphed for each year of age.
Results
Of the 51 053 COVID-19 patients enrolled in the final analysis, 27 667 (54.2%) had no chronic conditions, while 13 652 (26.7%), 6518 (12.8%) and 3216 (6.3%) were reported to have 1, 2, and 3 or more simultaneous conditions, respectively. Overall, a significant incremental gradient was observed for the association between multimorbidity and pneumonia (p<0.001); for 2 chronic conditions, the adjusted odds ratio (aOR) was 2.07 (95% confidence interval [CI], 1.95 to 2.20), and for ≥3 conditions, the aOR was 2.40 (95% CI, 2.22 to 2.60). A significant incremental gradient was also found for the relationship between multimorbidity and death (p<0.001); an aOR of 2.51 (95% CI, 2.30 to 2.73) was found for 2 chronic conditions and an aOR of 3.49 (95% CI, 3.15 to 3.86) for ≥3 conditions.
Conclusions
Underlying chronic conditions and multimorbidity are associated with pneumonia and death in Mexican COVID-19 patients. Future investigation is necessary to clarify the pathophysiological processes behind this association, given the high burden of chronic diseases in various countries, including Mexico.
Summary

Citations

Citations to this article as recorded by  
  • A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization
    Gilberto González-Parra, Javier Villanueva-Oller, F.J. Navarro-González, Josu Ceberio, Giulia Luebben
    Chaos, Solitons & Fractals.2024; 181: 114695.     CrossRef
  • Impact of COVID-19 on ‘Start Smart, Then Focus’ Antimicrobial Stewardship at One NHS Foundation Trust in England Prior to and during the Pandemic
    Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
    COVID.2024; 4(1): 102.     CrossRef
  • Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
    Tatjana T. Makovski, Jinane Ghattas, Stéphanie Monnier-Besnard, Lisa Cavillot, Monika Ambrožová, Barbora Vašinová, Rodrigo Feteira-Santos, Peter Bezzegh, Felipe Ponce Bollmann, James Cottam, Romana Haneef, Brecht Devleesschauwer, Niko Speybroeck, Paulo Jo
    Aging Clinical and Experimental Research.2024;[Epub]     CrossRef
  • Mortalidad en adultos mexicanos de 50 a 80 años de edad con multimorbilidad en un período de observación de 18 años
    Beatriz Novak, Daniel Lozano Keymolen
    Estudios Demográficos y Urbanos.2023; 38(1): 9.     CrossRef
  • Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination
    Lenin Domínguez-Ramírez, Francisca Sosa-Jurado, Guadalupe Díaz-Sampayo, Itzel Solis-Tejeda, Francisco Rodríguez-Pérez, Rosana Pelayo, Gerardo Santos-López, Paulina Cortes-Hernandez
    Vaccines.2023; 11(11): 1676.     CrossRef
  • Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA
    Giulia Luebben, Gilberto González-Parra, Bishop Cervantes
    Mathematical Biosciences and Engineering.2023; 20(6): 10828.     CrossRef
  • HEMOGRAM INDICATORS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY COVID-19 DEPENDING ON THE CHARLSON COMORBIDITY INDEX
    T. M. Homeliuk, M. I. Marushchak
    Bulletin of Problems Biology and Medicine.2023; 1(1): 161.     CrossRef
  • Correlates of In-Hospital COVID-19 Deaths: A Competing Risks Survival Time Analysis of Retrospective Mortality Data
    Ashish Goel, Alpana Raizada, Ananya Agrawal, Kamakshi Bansal, Saurabh Uniyal, Pratima Prasad, Anil Yadav, Asha Tyagi, RS Rautela
    Disaster Medicine and Public Health Preparedness.2022; 16(5): 1889.     CrossRef
  • Inference on the Beta Type I Generalized Half Logistic Distribution under Right-Censored Observation with Application to COVID-19
    Phillip Oluwatobi Awodutire, Ethelbert Chinaka Nduka, Maxwell Azubike Ijomah, Oluwatosin Ruth Ilori, Oluwafemi Samson Balogun, Niansheng Tang
    International Journal of Mathematics and Mathematical Sciences.2022; 2022: 1.     CrossRef
  • Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis
    Jacqueline Betsabe Puicón-Suárez, Sandra Zeña-Ñañez, Virgilio E. Failoc-Rojas
    PeerJ.2022; 10: e13437.     CrossRef
  • The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment
    Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, Keyao Yu, Ming Hu, Dongming Jiang, Guangwen Cao
    Journal of Hypertension.2022; 40(12): 2323.     CrossRef
  • Associations of symptom combinations with in-hospital mortality of coronavirus disease-2019 patients using South Korean National data
    Suyoung Jo, Hee-kyoung Nam, Heewon Kang, Sung-il Cho, Russell Kabir
    PLOS ONE.2022; 17(8): e0273654.     CrossRef
  • Epidemiological Profile and Social Welfare Index as Factors Associated with COVID-19 Hospitalization and Severity in Mexico City: A Retrospective Analysis
    Mario Antonio Téllez-González, Juan Antonio Pineda-Juárez, Juan Antonio Suárez-Cuenca, Mónica Escamilla-Tilch, Daniel Santillán-Cortez, Silvia García, Sofía Lizeth Alcaraz-Estrada, Juan Carlos Pérez-Razo, Carlos Alberto Delgado-Quintana, Joel Vargas-Herná
    International Journal of Environmental Research and Public Health.2022; 19(22): 14803.     CrossRef
  • Trends of COVID-19 Admissions in an Italian Hub during the Pandemic Peak: Large Retrospective Study Focused on Older Subjects
    Andrea Ticinesi, Antonio Nouvenne, Nicoletta Cerundolo, Alberto Parise, Beatrice Prati, Angela Guerra, Tiziana Meschi
    Journal of Clinical Medicine.2021; 10(5): 1115.     CrossRef
  • Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data
    Ismael Ibarra-Nava, Kathia G. Flores-Rodriguez, Violeta Ruiz-Herrera, Hilda C. Ochoa-Bayona, Alfonso Salinas-Zertuche, Magaly Padilla-Orozco, Raul G. Salazar-Montalvo, Mary Hamer Hodges
    PLOS ONE.2021; 16(3): e0239168.     CrossRef
  • Association of Kidney Disease With Outcomes in COVID‐19: Results From the American Heart Association COVID‐19 Cardiovascular Disease Registry
    Anjali Rao, Sagar Ranka, Colby Ayers, Nicholas Hendren, Anna Rosenblatt, Heather M. Alger, Christine Rutan, Wally Omar, Rohan Khera, Kamal Gupta, Purav Mody, Christopher DeFilippi, Sandeep R. Das, S. Susan Hedayati, James A. de Lemos
    Journal of the American Heart Association.2021;[Epub]     CrossRef
  • Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico
    Francisco Javier García-Alvarado, Melisa Alejandra Muñoz-Hernández, Elida Moran Guel, Marisela del Rocío González-Martínez, Maritza Argelia Macías Corral, Héctor Alberto Delgado-Aguirre
    Vector-Borne and Zoonotic Diseases.2021; 21(9): 720.     CrossRef
  • COVID‐19‐related deaths among women of reproductive age in Brazil: The burden of postpartum
    Roxana Knobel, Maíra L. S. Takemoto, Marcos Nakamura‐Pereira, Mariane O. Menezes, Vicente K. Borges, Leila Katz, Melania M. R. Amorim, Carla B. Andreucci
    International Journal of Gynecology & Obstetrics.2021; 155(1): 101.     CrossRef
  • Autosomal Dominant Polycystic Kidney Disease Does Not Significantly Alter Major COVID-19 Outcomes among Veterans
    Xiangqin Cui, Julia W. Gallini, Christine L. Jasien, Michal Mrug
    Kidney360.2021; 2(6): 983.     CrossRef
  • The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates
    Hongjie Hou, Jie Xu, Yang Li, Yadong Wang, Haiyan Yang
    The Journal of Allergy and Clinical Immunology: In Practice.2021; 9(11): 3944.     CrossRef
  • Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population
    Jennifer L. St. Sauver, Guilherme S. Lopes, Walter A. Rocca, Kavita Prasad, Michelle R. Majerus, Andrew H. Limper, Debra J. Jacobson, Chun Fan, Robert M. Jacobson, Lila J. Rutten, Aaron D. Norman, Celine M. Vachon
    Mayo Clinic Proceedings.2021; 96(10): 2528.     CrossRef
  • Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
    Yahya Mahamat-Saleh, Thibault Fiolet, Mathieu Edouard Rebeaud, Matthieu Mulot, Anthony Guihur, Douae El Fatouhi, Nasser Laouali, Nathan Peiffer-Smadja, Dagfinn Aune, Gianluca Severi
    BMJ Open.2021; 11(10): e052777.     CrossRef
  • Stability, Bifurcation, and a Pair of Conserved Quantities in a Simple Epidemic System with Reinfection for the Spread of Diseases Caused by Coronaviruses
    Jorge Fernando Camacho, Cruz Vargas-De-León, Hassan A. El Morshedy
    Discrete Dynamics in Nature and Society.2021; 2021: 1.     CrossRef
  • Evaluation of Treatment Outcome for Pneumonia among Pre-Vaccinated COVID-19 Patients with/without Comorbidity in a Public Hospital in Bengkulu, Indonesia
    Diana Laila Ramatillah, Siew Hua Gan, Syed Azhar Syed Sulaiman, Dama Puja, Usman Abubakar, Ammar Ali Saleh Jaber, Stefanus Lukas, Nina Jusnita
    Vaccines.2021; 9(12): 1411.     CrossRef
Measuring Out-of-pocket Payment, Catastrophic Health Expenditure and the Related Socioeconomic Inequality in Peru: A Comparison Between 2008 and 2017
Akram Hernández-Vásquez, Carlos Rojas-Roque, Rodrigo Vargas-Fernández, Diego Rosselli
J Prev Med Public Health. 2020;53(4):266-274.   Published online June 10, 2020
DOI: https://doi.org/10.3961/jpmph.20.035
  • 4,607 View
  • 194 Download
  • 9 Crossref
AbstractAbstract PDFSupplementary Material
Objectives
Describe out-of-pocket payment (OOP) and the proportion of Peruvian households with catastrophic health expenditure (CHE) and evaluate changes in socioeconomic inequalities in CHE between 2008 and 2017.
Methods
We used data from the 2008 and 2017 National Household Surveys on Living and Poverty Conditions (ENAHO in Spanish), which are based on probabilistic stratified, multistage and independent sampling of areas. OOP was converted into constant dollars of 2017. A household with CHE was assumed when the proportion between OOP and payment capacity was ≥0.40. OOP was described by median and interquartile range while CHE was described by weighted proportions and 95% confidence intervals (CIs). To estimate the socioeconomic inequality in CHE we computed the Erreygers concentration index.
Results
The median OOP reduced from 205.8 US dollars to 158.7 US dollars between 2008 and 2017. The proportion of CHE decreased from 4.9% (95% CI, 4.5 to 5.2) in 2008 to 3.7% (95% CI, 3.4 to 4.0) in 2017. Comparison of socioeconomic inequality of CHE showed no differences between 2008 and 2017, except for rural households in which CHE was less concentrated in richer households (p<0.05) and in households located on the rest of the coast, showing an increase in the concentration of CHE in richer households (p<0.05).
Conclusions
Although OOP and CHE reduced between 2008 and 2017, there is still socioeconomic inequality in the burden of CHE across different subpopulations. To reverse this situation, access to health resources and health services should be promoted and guaranteed to all populations.
Summary

Citations

Citations to this article as recorded by  
  • Causes of death among international travellers in Peru, 2017 to 2021
    Kasim Allel, Miguel M Cabada, Collen Lau, Deborah Mills, Richard C Franklin, Yan Zhu, Luis Furuya-Kanamori
    Journal of Travel Medicine.2024;[Epub]     CrossRef
  • Informal payments in health facilities in Peru in 2018: Analysis of a cross-sectional survey
    Laura Espinoza-Pajuelo, Patricia Mallma, Hannah Hogan Leslie, Patricia Jannet García, Sarthak Gaurav
    PLOS Global Public Health.2024; 4(1): e0001837.     CrossRef
  • An Examination of Inter-State Variation in Utilization of Healthcare Services, Associated Financial Burden and Inequality: Evidence from Nationally Representative Survey in India
    Aashima, Rajesh Sharma
    International Journal of Social Determinants of Health and Health Services.2024; 54(3): 206.     CrossRef
  • Prevalence and Determinants of Catastrophic Healthcare Expenditures in Iran From 2013 to 2019
    Abdoreza mousavi, Farhad lotfi, Samira Alipour, Aliakbar Fazaeli, Mohsen Bayati
    Journal of Preventive Medicine and Public Health.2024; 57(1): 65.     CrossRef
  • Consumer Financial Protection Versus Catastrophic Healthcare Expenditure in Zambia
    MccPowell Fombang, Richard Wamalwa Wanzala
    Public Health Challenges.2024;[Epub]     CrossRef
  • High cost drugs in Latin America: access and barriers
    Diego Rosselli
    Expert Review of Pharmacoeconomics & Outcomes Research.2023; 23(6): 619.     CrossRef
  • Determinants of Eye Care Service Utilization among Peruvian Adults: Evidence from a Nationwide Household Survey
    Antonio Barrenechea-Pulache, Andres Portocarrero-Bonifaz, Akram Hernández-Vásquez, Carlos Portocarrero-Ramos, Jenny Moscoso-Carrasco
    Ophthalmic Epidemiology.2022; 29(3): 339.     CrossRef
  • Financial risk protection from out-of-pocket health spending in low- and middle-income countries: a scoping review of the literature
    Taslima Rahman, Dominic Gasbarro, Khurshid Alam
    Health Research Policy and Systems.2022;[Epub]     CrossRef
  • THE IGNORED PANDEMIC OF PUBLIC HEALTH CORRUPTION: A CALL FOR ACTION AMID AND BEYOND SARS-COV-2/COVID-19
    Jorge A. Sánchez-Duque, Zhaohui Su, Diego Rosselli, Maria Camila Chica-Ocampo, Maria Isabel Lotero-Puentes, Ana M. Bolaños-Portilla, Manish Dhawan, Alfonso J. Rodríguez-Morales, Kuldeep Dhama
    Journal of Experimental Biology and Agricultural Sciences.2021; 9(2): 108.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health